In a story Feb. 24 about weight loss drugs and a story March 8 about Orexigen Therapeutics Inc.’s quarterly earnings, The Associated Press inaccurately described the ingredients in Orexigen’s drug Contrave. The pill combines bupropion, the active ingredient in the antidepressant Wellbutrin, with the anti-addiction drug naltrexone. Naltrexone is not the active ingredient in Wellbutrin.
PIANO END ARTICLE RECO
Please read our comment policy before commenting.